Notably, a CCL5 variant with a mutated BBXB motif and decreased GAG binding capacities efficiently inhibited HIV infection through CCR5 in vitro without affecting CCR5-mediated monocyte migration [45]. This evidence concerns the gene CCL5 and HIV infectious disease.